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Abstract
G-quadruplexes are tetraplex structures of nucleic acids that can form in G-rich sequences. Their presence and
functional role have been established in telomeres, oncogene promoters and coding regions of the human
chromosome. In particular, they have been proposed to be directly involved in gene regulation at the level of
transcription. Because the HIV-1 Nef protein is a fundamental factor for efficient viral replication, infectivity and
pathogenesis in vitro and in vivo, we investigated G-quadruplex formation in the HIV-1 nef gene to assess the
potential for viral inhibition through G-quadruplex stabilization. A comprehensive computational analysis of the nef
coding region of available strains showed the presence of three conserved sequences that were uniquely clustered.
Biophysical testing proved that G-quadruplex conformations were efficiently stabilized or induced by G-quadruplex
ligands in all three sequences. Upon incubation with a G-quadruplex ligand, Nef expression was reduced in a
reporter gene assay and Nef-dependent enhancement of HIV-1 infectivity was significantly repressed in an antiviral
assay. These data constitute the first evidence of the possibility to regulate HIV-1 gene expression and infectivity
through G-quadruplex targeting and therefore open a new avenue for viral treatment.
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Introduction
G-quadruplexes (G-4s) are inter- and intramolecular four-
stranded structures formed by G-rich DNA and RNA. G-4s are
based on the formation of G-quartets, which are stabilized by
Hoogsteen-type hydrogen bonds between guanines and by the
interaction with cations located between the tetrads. G-quartets
stack on top of each other to give rise to G-4s. G-rich
oligonucleotides can be very polymorphic, and the adopted
structures are dependent on several factors, including the base
sequence, strand concentration, loop connectivities, and
cations present. Such tetraplex DNAs have been an emerging
topic in nucleic acids research because of the recent indication
of their involvement in a series of key biological functions.
Initially G-4s have been shown to form in vitro [1] and in vivo
[2] in the G-rich sequence of telomeres: stabilization of the G-4
folded structure has been proposed as an effective approach to
inhibit telomerase activity in tumour cells [3]. Subsequently, it
has been shown that G-rich sequences are tightly clustered
immediately upstream and downstream of the transcription
start site in proliferation-associated genes, therefore
suggesting a role of tetraplexes as cis-acting regulatory
elements in gene expression [4], in particular in genes
important in cell signalling, which have representatives from the
six hallmarks of cancer [5].
G-rich sequences capable of forming G-4 were also found
within coding regions of the human genome, including
minisatellites [6], immunoglobin heavy chain switch regions [7]
and rDNA [8], and were shown to be the target of binding
proteins [9]. The folding of DNA G-4 most likely occurs during
single-stranded DNA formation, i.e. during transcription and
replication [10]. Recent work has shown that G-4 can also form
within coding regions: on the leading strand G-4s arise during
replication and promote genetic instability in human and yeast
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[11,12]; on the lagging strand G-4-forming sequences were
found to generate G loops during transcription both in vitro and
in Escherichia coli [13,14]. Further, association between G-4-
single nucleotide polymorphisms and expression of the
corresponding gene in individuals has been proposed [15].
Recently, cell-cycle dependent G-4 formation in living cells and
their stabilization by G-4 ligands has been demonstrated [16].
To date, a diverse array of G-4 stabilizing compounds have
been identified. General features of these G4-recognising
ligands include a large flat aromatic surface and cationic
charges [17]. Examples include perylenes, such as PIPER [18],
porphyrins, such as TMPyP4 [19], trisubstituted acridines, such
as BRACO-19 [20], natural macrocycles, such as Telomestatin
[21], and fluoroquinolone derivatives, such as Quarfloxin [22].
Some of these compounds have shown encouraging
anticancer activity in vitro, in vivo and in clinical trials [17,22].
The importance of G-4-forming sequences as regulatory
systems has been so far demonstrated only in eukaryotic cells,
however the presence of G-4 sequences has been recently
pinpointed also in prokaryotic cells [23–25]. Similarly, it is likely
that other organisms, such as viruses, have evolved analogous
regulatory mechanisms. Nevertheless, research in this area
has been so far very elusive.
The human immunodeficiency virus (HIV) is the etiological
agent of the acquired-immuno-deficiency syndrome (AIDS).
HIV establishes a persistent infection in human hosts, with the
depletion of CD4+ lymphocytes, the major target cells of viral
infection in vivo, eventually resulting in defective cellular
immunity, and thus leading to full-blown AIDS [26]. HIV is a
member of the genus Lentivirus, part of the family of
Retroviridae. Two types of HIV have been characterized: HIV-1
and HIV-2. The strains of HIV-1 can be classified into four
groups: the "major" group M, the "outlier" group O and two new
groups, N and P. More than 90% of HIV-1 infections belong to
HIV-1 group M [27]: within this group, at least nine genetically
distinct subtypes or clades (A, B, C, D, F, G, H, J and K) of
HIV-1 have been reported [28]. The viral genome consists of
two copies of positive single-stranded RNA that codes for
nine genes (gag, pol, env, tat, rev, vif, vpr, vpu, nef) [29].
To date, FDA-approved antiretroviral drugs belong to several
classes, based on their mechanism of action: 1) nucleoside
and 2) non-nucleoside RT inhibitors; 3) protease, 4) fusion and
5) integrase inhibitors and 6) CCR5 antagonists [27].
Combinations of the existing drugs are very effective in slowing
down progression to AIDS; however, the high mutation rate of
HIV gives rise to resistance which ultimately impairs
antiretroviral therapy. Therefore, there is an urgent need for
new anti-HIV drugs with an innovative mechanism of action,
possibly against highly conserved viral sites.
One attractive target for the anti-HIV therapy is the Nef
protein. Nef is a small myristoylated protein expressed early in
the HIV-1 life cycle: it is a fundamental factor for efficient viral
replication and pathogenesis in vivo; it also facilitates virus
replication and enhances viral infectivity in vitro [30–33]. An
essential role for Nef in vivo has been demonstrated in a
subset of long-term non-progressors, HIV-infected individuals
that do not progress to AIDS. Viral isolates from some of these
individuals exhibit either a deletion in the nef gene or defective
nef alleles [34]. In addition, rhesus macaques infected with an
engineered strain of SIV that lacked the functional Nef protein
also did not attain high viral loads and did not progress to
clinical disease [35]. Nef alters host cell processes by several
mechanisms: for example, to promote escape from the immune
system and infectivity, it downregulates CD4 and MHC I
expression on the cell surface, to enhance viral replication and
infectivity it activates CD4+ CTL and downregulates/interacts
with several cellular factors [36]. The Nef coding region, a 621
bp-long sequence located at the 3’-end of the viral genome,
partially overlaps with the 3’-long terminal region (LTR).
The presence of G-4 forming sequences in the nef gene has
never been reported. At the viral DNA level, G-4 forming
sequences have only been described in a single-stranded
portion (central DNA flap) of the reverse-transcribed pre-
integration HIV-1 genome, which specifically interacts with the
viral nucleocapsid protein and protects the pre-integrated
genome from nuclease degradation [37]. In the HIV-1 RNA
genome, a G-4 structure has been proposed to promote
dimerization of the two viral genome copies [38].
We present here the first comprehensive analysis of putative
G-4 forming sequences in the HIV-1 nef coding region. We
showed that three contiguous putative G-4 regions are present
and that at least two are extremely conserved among most
circulating HIV-1 strains. We provide evidence of their G-4
folding and stabilization in the presence of cations and G-4
binding compounds by spectroscopic and electrophoretic
techniques. Finally, we demonstrate that G-4 ligands impaired
Nef expression and significantly suppressed Nef-dependent
enhancement of HIV-1 infectivity.
Materials and Methods
All oligonucleotides were purchased from Sigma-Aldrich
(Milan, Italy). TMPyP4 and PIPER were purchased from
Calbiochem, (Merck Chemicals Ltd, Nottingham, UK).
BRACO-19 was obtained from ENDOTHERM GmbH,
(Saarbruecken, Germany).
G-4 analysis of the HIV-1 genome
The HIV-1 Nef coding region (strain HXB2/LAI, NC_001802)
was analyzed by QGRS Mapper (http://
bioinformatics.ramapo.edu/QGRS/index.php) for prediction of
G-4 forming sequences in both coding and non-coding strands
[39]. The putative G-4s were identified by the motif
GxNy1GxNy2GxNy3Gx, where x was the number of guanine (G)
tetrads and yn the length of loops connecting the G tetrads. The
following restrictions have been applied: i) the number of
tetrads had to be ≥ 2; ii) maximum length of QGRS was set to
30 bases; iii) at most one of the loops was allowed to be of
zero length; iv) loop size from 0 to 15. The found QGRS were
ranked based on the G-score, which is the likelihood to form a
stable G-4, according to the following principles: a) shorter
loops are more common than longer loops; b) G-4s tend to
have loops roughly equal in size; c) the greater the number of
G tetrads, the more stable the G-4.
Three G-4 putative sequences (Nef 8528 and Nef 8624 in
coding strand, Nef 8547 in non-coding strand) were evaluated
G-Quadruplexes in the HIV-1 nef Coding Region
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for their consensus sequence by aligning 3224 Nef sequences
(HIV-1, M Group) from the HIV database (http://
www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html)
using Jalview (http://www.jalview.org/). Aligned sequences
were searched for patterns expressed as Perl compatible
regular expressions using GNU grep command line tool.
Circular dichroism and UV spectroscopy
DNA oligonucleotides used for spectral analysis were
Nef8528 5’-GAGGAGGAGGTGGGT-3’, Nef8547 5’-
GGTCTTAAAGGTACCTGAGGTCTGACTGG-3’, Nef8624 5’-
GGGGGGACTGGAAGGG-3’ and their complementary
sequences, Nef8528-Compl ACCCACCTCCTCCTC, Nef8547-
Compl CCAGTCAGACCTCAGGTACCTTTAAGACC, Nef8624-
Compl CCCTTCCAGTCCCCCC. All oligonucleotides were
diluted from stock to the final concentration (4 µM) in lithium
cacodylate buffer (10 mM, pH 7.4) and, where appropriate, KCl
100 mM. All samples were annealed by heating at 95 °C for 5
min, gradually cooled to room temperature and measured after
24 h. Compounds at 16 µM final concentration were added
after DNA annealing. CD spectra were recorded on a
Jasco-810 spectropolarimeter (Jasco, Easton, MD, USA)
equipped with a Peltier temperature controller using a quartz
cell of 5-mm optical path length and an instrument scanning
speed of 100 nm/min with a response time of 4s over a
wavelength range of 230-600 nm. The reported spectrum of
each sample represents the average of 2 scans at 20°C and is
baseline-corrected for signal contributions due to the buffer.
Observed ellipticities were converted to mean residue ellipticity
(θ) = deg × cm2 × dmol−1 (mol. ellip.). For the determination of
Tm, spectra were recorded over a temperature range of 20-95
°C, with temperature increase of 5 °C/min. Tm values were
calculated as the first derivative of the melting profiles. For UV
thermal unfolding, DNA oligonucleotides were diluted to final
concentration of 4 µM or 40 µM. UV spectra were recorded on
Lamba25 UV/Vis spectrometer (PerkinElmer) equipped with a
Peltier temperature controller using a quartz cell of 10-mm
optical path length and measuring absorbance at 295 nm. UV
spectra were recorded over a temperature range of 20-95°C,
with temperature increase of 1°C/min. The autozero function
was applied on the corresponding buffer sample at 20°C.
Taq polymerase stop assay
DNA templates bearing the sequences of interest with G
possibly involved in G-4 formation (in bold) and the primer
annealing region (underlined) were: Nef8528pol 5’-
TTGGAGGAGGTGGGTTTTCCAGTCACACACCTCAG-3′,
Nef8624pol 5’-
TTGGGGGGACTGGAAGGGTTTTCCAGTCACACACCTCAG-
3’, Nef8547pol 5’-
TTGGTCTTAAAGGTACCTGAGGTCTGACTGGTTTTCGAGA
CACAGCTCAG-3’. DNA templates bearing control sequences
were: (NefControl1 5’-TTGTCGTCACAGTCTGACTGTTTT
CCAGTCACACACCTCAG-3′ and NefControl2 5’-
TTGTCGTTGAAGATAGCCGTGTAGCTGACGTTTTTCGAGA
CACAGCTCAG-3’). DNA primers were: 5′-
ATCGATCGCTTCTCGTCTGAGGTGTGTGACTGG-3′ and 5’-
ATCGATCGCTTCTCGTCTGAGCTGTGTCTCG-3’, where the
underlined nucleotides are those complementary to the
templates. Primers were 5′-end-labeled with [γ-32P] ATP using
T4 polynucleotide kinase for 30 min at 37°C and purified with
Illustra MicroSpin G-25 Column (GE Healthcare, Life Sciences,
Milan, Italy).
DNA templates were diluted from stock to the final
concentration (50 µM) in lithium cacodylate buffer (10 mM, pH
7.4) with 100 mM KCl and then let fold by heating at 95 °C for 3
min, gradually cooled to room temperature, and incubated at 4
°C overnight. DNA templates were further diluted to a
concentration of 1 µM and mixed with DNA primer (200 nM),
1X PCR reaction buffer (Applied Biosystems, Carlsbad,
California, USA), and 0.1 mM dNTPs. Where appropriate,
TMPyP4 was added. AmpliTaq Gold DNA polymerase (1U/
reaction, Applied Biosystem, Carlsbad, California, USA) was
then added. Samples were subjected to 30 cycles: 95°C 30
sec, 60°C 30 sec, 72°C 30 sec. Reactions were stopped by
ethanol precipitation. Marker lanes were generated on the
labelled double stranded PCR product using the Maxam &
Gilbert protocol. Briefly, ethanol precipitated PCR products
were treated with formic acid (12 µl) for 5 min at 20°C.
Reactions were stopped by ethanol precipitation. Samples
were treated with piperidine 1 M for 30 min at 90°C; reactions
were stopped on ice for 5 min. Samples were concentrated in
SpeedVac. Markers corresponded to the C-rich complementary
strand. The primer extension products and markers were
separated on a 12% polyacrylamide denaturing gel and
visualized by phosphorimaging (Typhoon FLA 9000, GE
Healthcare, Milan, Italy).
Cloning
Plasmid p-Nef-HA EGFP-N1 containing Nef-HA fused to
GFP was obtained by PCR amplification of the Nef-HA coding
sequence (strain HXB2/LAI; NC_001802) in plasmid
pNefHABJ5 (kindly donated by Prof. M. Pizzato, Centre for
Integrative Biology, University of Trento, Trento, Italy). PCR
was performed using primers prFNef (5’-
TAAGCTAGCACGCGTCATGGGTGGCAAGTGG-3’) and
prRNef (5’-ACTGAATTCTAGCGTAATCTGGGACGTC-3’),
which introduced NheI and EcoRI restriction sites for
subsequent insertion in the pEGFP-N1 vector (Clontech,
Mountain View, CA, USA). The obtained coding sequence of
the fused Nef-HA GFP protein was confirmed by sequencing.
Flow cytometry analysis
For FACS analysis, 8 × 104 of HEK 293T cells were seeded
in a 12-well plate in 1 ml of DMEM/10% FBS medium and
incubated for 24 hours. Cells were next transfected with pNef-
HA EGFP-N1 by TransIT-293 Transfection Reagent (Mirus,
Madison, WI, USA). After 4 hours, cells were treated with
TMPyP4 or TMPyP2 (10 µM) and incubated overnight. After
trypsinization, cells were washed with PBS and resuspended in
500 µl of PBS. To evaluate GFP expression, a total of 30000
events were acquired for each sample with an LRS 2
instrument using FACS DIVA Software (BD Bioscience, San
Jose, CA, USA) and analyzed with FlowJo (Tree Star, OR,
USA).
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Cytotoxicity assays
Evaluation of the cytotoxicity of the compounds in HEK 293T
cells was performed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay. HEK 293T cells
were seeded in 96-well plate (1,5 x 104/well) and grown
overnight. Test compounds were added to one series of
triplicate wells and incubated at 37°C. After 48 h, MTT (Sigma-
Aldrich, Milan, Italy) solution (5mg/ml in PBS) was added and
incubated at 37°C. After 4h, a solubilizing solution (SDS 10%,
HCl 10mM) was added to dissolve the formazan crystals and
incubated overnight at 37°C. The blue-purple formazan
corresponding to metabolically active cells was then measured
spectrophotometrically. The absorbances at 620nm were read
in a computer-controlled spectrophotometer with a 96-well
plate reader (Sunrise, Tecan) using the program Magellan 4.0.
The percentage of cell viability was calculated by using the
median absorbance value of three wells compared to the
control’s wells. CC50 was the concentration of the test
compounds that caused death of 50% cell population.
TZM-bl cells [40,41] were seeded in 96-well plates (2 x 104)
and grown overnight to permit adherence. Cells were then
incubated with compounds in DMSO carrier solvent and
incubated at 37°C. After 48 h, cytotoxicity was assessed using
the Cell Titer Blue reagent (Promega) and the manufacturer’s
protocol.
Antiviral assays
Viral stocks were prepared by transfection of HEK 293T cells
(ATCC) with wild-type and Nef-defective (ΔNef) proviral
genomes (NL4-3 strain) and amplified in the T cell line, MT2
(NIH AIDS Research and Reference Reagent Program) as
previously described [42–44]. HIV-1 infectivity was measured
using the TZM-bl reporter cell line [40,41] (NIH AIDS Research
and Reference Reagent Program). TZM-bl cells support HIV-1
replication in a Nef-dependent manner and contain a luciferase
reporter under the control of the HIV-1 promoter [41,45]. Cells
were seeded in 96-well plates (2 x 104) and grown overnight to
permit adherence prior to treatment and viral infection.
TMPyP4 was solubilized in DMSO and preincubated separately
with both the cell culture medium (100 µL) and wild-type HIV-1
or ΔNef HIV-1 (100 µL) for 4 h prior to infection in a combined
final volume of 200 µL. After 48 h at 37°C, the cells were
washed with PBS and lysed in luciferase lysis buffer (Promega)
by rocking for 15 min. Lysates (40 µL) were transferred to white
96-well plates, and 50 µL luciferase reagent (Promega) was
injected into each well. Readings were recorded with a delay
time of 2 s and an integration period of 10 s.
Results
Computational analysis of the HIV-1 Nef coding region
for the presence of putative G-4 forming regions
The HIV-1 Nef coding region (strain HXB2/LAI, NC_001802)
was analysed with QGRS Mapper which is an online
algorithms-based software program for recognition and
mapping of putative Quadruplex forming G-Rich Sequences
(QGRS) [39]. The found QGRS were ranked based on the G-
score, which is the likelihood to form a stable G-4.
Since the viral genome is retrotranscribed into double-
stranded DNA and inserted into the human genome, analysis
for QGRS was performed also on the reverse strand of the nef
coding gene.
Four putative QGRS were located in the nef gene (Table 1):
two on the forward (positions 8528 and 8624, where +1 is the
first base of the HIV-1 genome as reported in GenBank,
NC_001802) and two on the reverse strand (positions 8547
and 8727). In particular, the three that displayed the highest G-
score (≥ 20) were also adjacent to one another: the first on the
forward strand (Nef8528) and the second on the reverse strand
(Nef8547) were separated by just 4 nucleotides (nts); the
second from the third sequence on the forward strand
(Nef8624) by 48 nts (Figure 1A-B). If these three sequences
were able to fold in G-4, this region of the HIV-1 proviral
genome could constitute an important cluster of non-canonical
DNA structures with possible effects on polymerase processing
(and therefore impact on replication and transcription events)
(Figure 1C-D). It is interesting to note that all selected G-4
putative sequences code for amino acids of the Nef core, which
is the most conserved region of the protein and is essential for
interaction with cellular proteins to mediate key viral functions
[46–48] (Figure 1D).
To establish the importance of the identified sequences from
a virus standpoint, the degree of conservation in terms of
sequence and G-4 formation among HIV-1 strains was
assessed.
Initially, the presence of the exact sequences identified in the
HIV-1 HXB2/LAI strain was analysed in 3224 nef sequences of
the HIV-1 M group reported in the HIV database (http://
www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html).
Among these, 1538 sequences belonged to clade B, 612 to
clade C, 486 to clade A, and 588 to other clades. As shown in
Table 2, Nef8528, Nef8547 and Nef8624 were fairly well
conserved in the M group, especially in the B subtype, where
conservation was higher with respect to the other clades of the
M group. Next, the possibility of G-4 formation was statistically
analysed by maintaining the number and size of G repeats,
while varying loop regions. Two cases were considered: in
Table 1. Putative G-quadruplex forming sequences within
the HIV-1 nef gene (HIV-1 strain HXB2/LAI, NC_001802) in
the forward and reverse strand.
Position in the F
strand Length
Putative G-4 nef
sequence G-score
8528 15 GGAGGAGGAGGTGGG 17-21
8547 29
CCAGTCACACC
TCAGGTACCTTT
AAGACC
21
8624 16 GGGGGGACTGGAAGGG 16-20
8727 30
CCAGGGCCAGG
GGTCAGATATC
CACTGACC
12
doi: 10.1371/journal.pone.0073121.t001
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instance i) loops could diverge in base composition while
maintaining a constant length; in instance ii) both loop
composition and length were allowed to vary. As shown in
Table 2, Nef8547 and Nef8624 reached a degree of
conservation higher than 95% in both cases across all
considered HIV subtypes. Nef8528 was conserved to a
significant extent in clades A and B (up to 66.3%); its presence
was negligible only in clade C. Consensus sequences and
base conservation in each position are reported in Table 3.
Overall these data indicate that the G-4 pattern, therefore the
possibility of G-4 folding, in the selected G-rich sequences in
the Nef coding region is extremely conserved among
circulating HIV-1 strains, at least for Nef8547 and Nef8624.
G-rich sequences in the nef region are able to fold in
G-4
The actual folding of the selected nef sequences in a G-4
conformation was initially assessed by circular dichroism (CD)
spectroscopy. In the case of Nef8528, which presents five GG-
repeats, we used the minimal sequence that could fold into G-4
(see Materials and Methods). Since monovalent cations, in
particular K+, are known to stabilize G-4s [49], the three nef
sequences were incubated in the presence of increasing
concentrations of K+ or Na+. Both cations increased the CD
signal, with K+ exhibiting a remarkably higher effect than Na+.
CD analysis is typically used to obtain information on the G-4
topology: in particular, a parallel-type G-4 conformation is
manifested by a maximum at 260 nm and a minimum at 240
nm, while an antiparallel topology exhibits two maxima at 290
nm and 240 nm and a minimum at 260 nm [50]. Nef8528 and
Nef8624 displayed a clear parallel-type conformation upon
addition of K+ and Na+, with a maximum at 260 nm and a
minimum at 240 nm (Figure 2). Conversely, Nef8547 presented
a maximum at around 275 nm and a negative peak at 240 nm,
with low K+/Na+ dependence. Therefore, the 7-nt-long loop
Nef8547 apparently did not naturally fold into a canonical G-4
conformation: to note, however, that similar CD spectra have
Figure 1.  Putative G-forming regions in the HIV-1 nef coding region.  A) Scheme of G-4 formation within the double-stranded
DNA of the nef region: Nef8528, Nef8547, Nef8624 G-4 structures are shown in blue, green and red, respectively. The numbers of
nts separating each G-4 structure are indicated. The scheme indicates the possibility of formation of a cluster of non-canonical DNA
structures within a small portion (112 nts) of the HIV-1 genome. B) Nucleotide sequence of the nef coding region where three
putative G-4 sequences were identified. Nef8528 is shown in blue and Nef8624 in red. Nef8547 was identified on the non-coding
strand, thus the reverse complementary sequence is shown on the upper strand (in green). C) Scheme of the HIV-1 nef coding
sequence with numbering referring to the HIV-1 strain HXB2/LAI, NC_001802. D) Scheme of the aminoacidic sequence of the Nef
protein indicating reported structural domains [73]. The protein moiety coded by the G-4 rich nucleotide region is highlighted by the
rectangular yellow shape, indicating involvement of the conserved N-terminal Nef core region. Note that the first three nts of the
Nef8528 sequence exactly code for the first amino acid of the protein core region.
doi: 10.1371/journal.pone.0073121.g001
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been reported for G-4 forming oligonucleotides with long loops
(i.e. at least two loops ≥ 5 nts) [51].
Stability of the G-4 structures was next evaluated by CD
thermal unfolding and melting temperatures (Tm) were
calculated as the first derivative of the melting profiles (Figure 3
and Table 4). In all cases the CD signal decreased with
increasing temperature. For Nef8547 and Nef8624 a single
transition between 25°C and 95°C was appreciable leading to
discrete Tm values (35°C and 59°C, respectively, Table 4). For
Nef8528 two transitions were present: a first structural variation
at 39°C and a second at Tm > 50°C, where a clear inflection
point was not observed. This behaviour could also be evinced
by spectra overlapping, where two isosbestic points (asterisks
in Figure 3) were detected, indicating the presence of at least
three spectroscopically distinct species: the initial G-4
structure, a second folded form, likely a more flexible G-4
conformation, and the unfolded random coiled structure. In
addition, Tm values measured by UV thermal unfolding at
oligonucleotide concentration of 40 µM were very similar to
those obtained at 4 µM (Table 4), indicating a prevalent
intramolecular G-4 folding.
Several compounds have now been reported to stabilize the
G-4 structure. Three G-4 ligands with different central cores
(i.e. porphyrin for TMPyP4, acridine for BRACO-19, and
perylene for PIPER) were incubated in the presence of each of
the three nef G-rich oligonucleotides to check for the
compound ability to induce/stabilize the G-4 topology. CD
thermal unfolding analysis was employed to check stabilization
of the G-4 conformation imposed by the G-4 ligands. CD
spectra of all three oligonucleotides in the presence of G-4
ligands were characteristic of G-4 conformations. In particular,
Nef8528 and Nef8624 maintained the initial parallel-like
topology with TMPyP4 and PIPER; in the presence of
BRACO-19 an additional positive peak appeared at 290 nm,
which is characteristic of a G-quadruplex topology and might
depict a shifting towards a hybrid topology. In the case of
Nef8547, PIPER induced an antiparallel-like spectrum, while
TMPyP4 and BRACO-19 stabilized hybrid-type G-4 structures
(Figure 4A), indicating that G-4 ligands are able to drive
Nef8547 folding into a G-4 conformation. To note that in most
cases an induced CD spectrum was observed in the UV/Vis
absorption region of the ligands, further confirming
oligonucleotide/compound interaction. G-4 ligands highly
stabilized the G-4 conformations of Nef8528 and Nef8547
(Table 4). Nef8624 in general was less efficiently stabilized,
likely due to the higher innate stability of this latter
oligonucleotide. In cases where two transitions were observed,
Tm values for each transition were reported (Table 4). These
data altogether confirm the ability of the nef sequences to fold
Table 2. Statistical analysis of the conservation grade of the G-4 nef sequences or their G-4 patterns.
G-4 name G-4 sequence or pattern Conservation grade (%)
  Group M Clade A Clade B Clade C
Nef8528 GGAGGAGGTGGG 13.9% 0.6% 27.2% 0.3%
A) G2 X1 G2 X1 G2 X1-2 G2 15.7% 2.4% 29.9% 0.5%
B) G2 X0-7 G2 X0-7 G2 X0-7 G2 46.8% 57.6% 66.3% 9.3%
Nef8547 CCAGTCAGACCTCAGGTACCTTTAAGACC 24.1% 0.0% 39.2% 11.1%
A) C2 X7 C2 X7 C2 X7 C2 98.6% 97.6% 99.1% 98.5%
B) C2 X1-10 C2 X1-10 C2 X1-10 C2 99.0% 99.4% 99.1% 98.9%
Nef8624 GGGGGGACTGGAAGGG 66.4% 13.3% 86.5% 58.8%
A) G2 X2 G2 X3 G2 X2-3 G2 98.0% 95.2% 97.9% 98.7%
B) G2 X0-7 G2 X0-7 G2 X0-7 G2 99.9% 99.4% 99.9% 100.0%
In bold bases possibly involved in G-4 folding.
doi: 10.1371/journal.pone.0073121.t002
Table 3. Consensus sequences and percentages of base conservation at each position.
Nef8528 G G A G G A G G A G G T G G G               
Consensus seq G G A G G A G G A G G T A G G               
% consensus 76 96 90 35 94 87 65 99 95 50 99 99 51 99 99               
Nef8547 C C A G T C A C A C C T C A G G T A C C T T T A A G A C C
Consensus seq C C A G T C A C A C C T C A G G T A C C T T T A A G A C C
% consensus 99 99 97 99 99 91 98 85 80 99 99 75 99 99 86 99 99 77 99 99 86 79 98 90 99 99 91 99 99
Nef8624 G G G G G G A C T G G A A G G G              
Consensus seq G G G G G G A C T G G A A G G G              
% consensus 98 99 99 99 99 99 99 99 99 99 99 99 68 99 99 99              
Bases involved in G-4 folding are shown in bold.
doi: 10.1371/journal.pone.0073121.t003
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in G-4: G-4 ligands can bind, induce and stabilize their G-4
conformations.
Since the G-rich nef sequences in the proviral genome are
normally embedded in a DNA double-helix, TMPyP4 was
incubated with each nef oligonucleotide in the presence of its
complementary counterpart in order to assess the ability of a
G-4 ligand to promote G-4 folding from a double-stranded (ds)
DNA. CD spectra of the ds oligonucleotides in the absence or
in the presence of K+ were very similar and characteristic of a
B-DNA [52]. However, when TMPyP4 was added, the CD
spectra clearly shifted, presenting two maxima at 290 and 260
nm, which are indicative of a G-4 conformation (Figure 4B).
Since TMPyP4 absorbance below 300 nm is extremely low
[53], the observed molar ellipticity variation must be due to
changes in the absorbance of the nucleic acid. These data
show that nef sequences are normally present in a B-DNA
conformation within the double-helix, and that a G-4 binder is
able to induce their folding in G-4.
G-4 folding in the selected sequences was additionally
proved by the Taq polymerase stop assay. The three G-4 nef
oligonucleotides were designed in order to contain additional
flanking bases at both the 5’- and 3’-ends (see Materials and
Methods Section); in particular, an additional sequence at their
3’-end was used as primer annealing region. A 4-T linker
region was added to separate the 3’-end of the primer and the
first G of the G-4 portion. An additional oligonucleotide lacking
the possibility to fold in G-4 was designed and used as
negative control. Primer annealing and G-4 folding were
obtained by incubating the template G-4 forming
oligonucleotides and the primer in K+ buffer at 95°C and slowly
Figure 2.  CD spectra of the putative G-4 forming oligonucleotides in the nef region.  For each oligonucleotide, CD spectra
were measured in the absence or presence of increasing concentrations (50-150 mM) of K+ or Na+ cations.
doi: 10.1371/journal.pone.0073121.g002
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cooling down to room temperature. Taq polymerase was
incubated with the different template/primer combinations in the
presence of increasing amount of TMPyP4. As shown in Figure
5A, in the presence of both Nef8528 and Nef8624 templates,
increasing drug concentrations induced arrest of the DNA
polymerase processing at the T linker region, just before the
G-4 folded region (lanes 10-12 and 17-18, Figure 5A), while no
effect was detected in the negative control (lanes 2-6, Figure
5A). In the case of the Nef8624 template, at low amounts of
TMPyP4, a polymerase pausing site was observed
corresponding to the second G-tract of the Nef8624
oligonucleotide (* symbol, lanes 15-16, Figure 5A). In addition
the polymerase was partially inhibited also in the absence of
TMPyP4 (¤ symbol, lane 14, Figure 5A). We ascribed this
behaviour to the fact that the G-4 conformation of Nef8624 was
inherently very stable in the presence of K+ (Tm 59.8°C, see
Table 3) and thus could affect polymerase activity even without
G-4 ligands, similarly to other reported G-4 structures [54]. In
the case of the Nef8547 template, several stop sites were
observed in the G-4 forming template, while the polymerase
was not inhibited in the control (compare lanes 2-5 and 7-10,
Figure 5B). In particular, stop sites were clustered at G bases
at low TMPyP4 concentrations (* symbols, lane 8, Figure 5B)
and at the T-linker at higher G-ligand amounts (lane 10, Figure
5B).
Overall these data indicate that a G-4 binder can induce and
stabilize the G-4 conformations at the nef DNA level.
Figure 3.  CD thermal unfolding of the G-4 nef oligonucleotides.  CD spectra measured at increasing temperatures (25-95°C)
are shown on the left. Arrows indicate spectral trends at the corresponding wavelengths. Asterisks indicate isosbestic points. Plots
of molar ellipticity values (black circles) measured at the indicated wavelength (corresponding to positive peaks) as a function of
temperature are reported on the right. Arrows indicate Tm points.
doi: 10.1371/journal.pone.0073121.g003
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Stabilization of nef G-4 sequences by G-4 ligands
affects gene expression
To check the effect of G-4 stabilizing ligands on gene
expression, a GFP-based reporter gene assay was set up. The
nef gene was cloned upstream of a GFP coding region in a
plasmid optimized for protein expression in mammalian cells. In
principle, G-4 folding in the nef sequence should impair the
polymerase activity on the DNA template, therefore reducing
expression of the fused Nef-GFP protein. Transfected cells
were treated with TMPyP4 (10 µM) or a control compound,
TMPyP2, a structural analogue of TMPyP4 which is not able to
bind G-4s [55]; both compounds did not show toxicity on
HEK293T cells up to 100 µM (data not shown). GFP
fluorescence was quantified by flow cytometry-based analysis.
As shown in Figure 6A, mean of fluorescence consistently
decreased in the presence of TMPyP4, while slightly increased
upon treatment with the control TMPyP2 indicating a selective
impairment of gene expression mediated by the interaction of
the G-4 ligand with the nef sequence.
Effect of nef G-4 binding compounds on HIV-1
infectivity
Having observed an impairment of Nef protein expression
levels, the effect of G-4 stabilizing ligands was next assessed
in HIV-1 infected cells. As Nef has been previously shown to
enhance HIV-1 infectivity [31,33,56,57], we evaluated the
impact of TMPyP4 on infectivity using the TZM-bl reporter cell
line [40,41]. TZM-bl cells support HIV-1 replication in a Nef-
dependent manner and contain a luciferase reporter driven by
the HIV-1 LTR in response to infection with HIV-1 [41,42]. As
shown in Figure 6B, TMPyP4 impaired the enhancement of
Nef-mediated viral infectivity in a dose-dependent manner,
while the negative control (TMPyP2) had no effect (Figure 6C).
In addition, a Nef-deleted virus (ΔNef) showed no significant
effects by treatment with either TMPyP4 or TMPyP2 at the
Table 4. Tm and ΔTm of the three G-4 nef sequences (4 µM
and 40 µM) in the absence and presence of G-4 ligands (16
µM) measured by CD and UV spectroscopy.
G-4 DNA Drug added Tm (°C) 4 µM* ΔTm (°C) 4 µM** Tm (°C) 40 µM*
Nef8528 - 39, > 50 - 41
 TMPyP4 57 18 -
 BRACO 69 30 -
 Piper 80 41 -
Nef8547 - 35 - 37
 TMPyP4 56 21 -
 BRACO 48 13 -
 Piper 56 21 -
Nef8624 - 59 - 58
 TMPyP4 72 13 -
 BRACO 64/75 5/16 -
 Piper 61/>100 2/> 40 -
*. Average standard deviation was 0.3.
**. Average standard deviation was 0.4.
doi: 10.1371/journal.pone.0073121.t004
highest concentrations (Figure 6B-C). Cytoxicity assays further
confirmed the observed impairment of viral infectivity as
minimal toxicity was observed over the range of concentrations
tested (0.1-6 µM) (Figure 6D). Taken together, these results
provide support for a G-4 mediated, Nef-directed anti-retroviral
mechanism of action.
Discussion
To our knowledge, this is the first report indicating a) the
presence of conserved G-rich sequences that can fold in the
G-4 conformation within the HIV-1 proviral genome, b) the
important role played by G-4 stabilization in both polymerase
and viral infectivity inhibition.
The Nef protein has a fundamental function in vivo and its
lack of activity (observed in Nef mutant HIV strains) prevents
progression to the clinical development of AIDS [34]; therefore
its depletion could have critical antiviral effects.
Here we demonstrated that in the HIV-1 Nef coding region
three G-rich/G-4 prone tracts were closely clustered and
located on both the leading and lagging strands where G-4-
mediated induction of genetic instability and arrest of RNA-
dependent polymerase have been described [11,13]. In
addition, in a supercoiled environment, i-motif conformations
may arise in the C-rich complementary sequences
independently of G-4 formation and pH [1,58]. We thus foresaw
the possibility of creating a structured environment upon
induction of non-canonical nucleic acid conformations, with the
possibility of blocking enzymes involved in Nef protein
expression. The identified G-4 forming sequences comprised at
least four tracts of two consecutive Gs, with the possibility to
form G-4s with two stacked tetrads. Although in principle two
G-tetrads would confer less stability than more extended G-
tetrads, the existence and biological role of G-4s with two
stacked tetrads has been reported in several cases [59–63].
Interestingly, in certain instances, two-tetrads G-4s showed
higher stability than three-tetrads G-4s [64–67].
Upon analysis of all HIV-1 strains available in databases, we
demonstrated that the G-rich region in the nef coding gene,
and in particular the G pattern necessary for G-4 folding, is
conserved within the HIV-1 M group and in its subtypes largely
distributed worldwide. This information suggests that G-4
structures may form at this level and may also be involved in
important viral functions. If this was the case, we argued that
stabilization induced by G-4 binders would exert an effect
observable at the viral level. All three putative G-4 nef
sequences were able to fold in a G-4 conformation in the
presence of G-4 binders. In most cases G-4 ligands varied the
initial G-4 topology and augmented the Tm during temperature
unfolding experiments, indicating an effective interaction
between them and the G-4 nef oligonucleotides. Importantly, all
G-4 nef sequences were able to form G-4 structures even in
the presence of their complementary oligonucleotides. In the
case of Nef8528 and Nef8547, they both existed in a fully
double-stranded state and G-4 folding was induced upon
incubation with the G-4 ligand. Conversely, Nef8624 was
present in a partial G-4 topology even in the absence of the
G-4 binder, as attested by both CD analysis and partial
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inhibition of the DNA polymerase activity prior to G-4
compound addition. This is in accordance with the higher Tm
measured for the G-4 structure of Nef8624.
Most importantly, the ability to induce G-4 folding with
consequent inhibition of viral infectivity was shown in HIV-1
infected cells. Within the cellular context of viral infection, the
G-rich sequences are embedded in a double stranded state
and yet small amounts of G-4 ligand were sufficient to impair
the Nef-mediated enhancement of HIV-1 infectivity. The
significant effect observed on the wt HIV-1 virus in Nef
sensitive cells [45] and the negligible effect on the ΔNef virus
further indicate an efficient inhibition of Nef protein expression.
Recent research on G-4 has revealed strong stabilization of
tetraplex structures at the RNA level [68,69]. It is thus possible
that, besides the DNA, the nef mRNA is also stabilized by G-4
compounds, therefore enhancing inhibition of Nef expression in
infected cells. The fact that Nef8624, the most stable G-4
sequence, was able to pause the polymerase independently of
the presence of G-4 ligands, suggests that it may naturally
function as a molecular switch to assist protein expression or
other unanticipated viral functions.
Moreover, G-4 stabilization within the nef coding region of
the viral genome may impair not only Nef expression through
inhibition of transcription that directly generates mRNAs, but
also overall transcription for production of new copies of the
RNA genome to be assembled in the viral progeny.
An additional point to be considered is that available G-4
ligands were developed principally against the telomeric G-4,
Figure 4.  CD spectra of G-4 nef single-stranded or double-stranded oligonucleotides in the presence of G-4 ligands.  A) CD
spectra of G-4 nef single-stranded oligonucleotides in the presence of TMPyP4, BRACO-19 or PIPER. Addition of ligands stabilized
G-4 conformations and generated ICD bands in the UV/Vis absorption regions of G-4 ligands. B) CD spectra of G-4 nef double-
stranded oligonucleotides in the presence or absence of K+ and TMPyP4. Addition of the G-4 binding compound induced shifting
from double-stranded DNA spectra to mixed type G-4 signatures in all three cases.
doi: 10.1371/journal.pone.0073121.g004
G-Quadruplexes in the HIV-1 nef Coding Region
PLOS ONE | www.plosone.org 10 August 2013 | Volume 8 | Issue 8 | e73121
and were shown to kill tumour cells through telomere
dysfunction and telomerase inhibition [70,71]. G-4 stabilizing
compounds interact with the G-4 structure both at the aromatic
G-quartet level, which is common to all G-4 conformations, and
at the loops, which conversely are unique to each G-4 folding
[72]. Here we have shown that the G-4 ligand TMPyP4 is
effective towards the virus with minimal effect on cell viability.
Therefore a therapeutic window can be envisaged that would
consent the employment of known G-4 binders as anti-HIV
compounds. In addition, rational design of new G-4 ligands
directed towards the tested G-4 nef sequences would likely
augment the selective effects towards the virus. Detailed
structural characterization of the G-4 nef sequences will be the
first step to allow molecular modelling of new G-4 binding
leads.
The results presented here may open a new avenue in the
development of antiviral compounds with an unprecedented
mechanism of action.
Figure 5.  Taq polymerase stop assay.  A) and B) Templates containing the G-4 nef sequences Nef8528, Nef8624 and Nef8547,
a 4-T linker and a primer annealing region were allowed to fold and anneal to the P32-5’-end labelled primer in K+ 100 mM, treated
with increasing concentrations of TMPyP4 (0-2 µM) and subjected to Taq polymerase extension. The control template contained a
sequence unable to fold in G-4, and the same 4-T linker and primer annealing region as the nef templates. A) The * symbol
indicates pausing sites in the G-4 region of nef templates. The ¤ symbol indicates a polymerase stop site obtained prior to addition
of TMPyP4 in Nef8624. Lanes 1, 7 and 13 (A), and lanes 1 and 6 (B) were Maxam and Gilbert marker lanes performed on the
double stranded PCR amplified region. Markers indicate the C-rich complementary strand.
doi: 10.1371/journal.pone.0073121.g005
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Figure 6.  Effects of the stabilization of the nef G-4s by
TMPyP4 on gene expression and viral infectivity in Nef
sensitive cells.  A) Effect of TMPyP4 and TMPyP2 on Nef-
GFP expression measured by flow-cytometry. HEK 293T cells
were transfected with a Nef-GFP encoding plasmid and treated
with TMPyP4 or TMPyP2 (10 µM) for 24 h. Results are shown
as percent mean of fluorescence relative to the control cells
incubated ± SD (n = 4). Statistical difference was observed for
TMPyP4 (p<0.05), but not for TMPyP2. B) and C) TZM-bl cells
were infected with wild-type (black bars) and ΔNef (grey bars)
HIV NL4-3 in the presence of either the G-4 ligand, TMPyP4
(B), or the negative control compound, TMPyP2 (C). After 48 h,
infectivity was assessed as relative luciferase activity in
infected cells. Results are shown as percent infectivity relative
to the control cells incubated with carrier solvent (DMSO) ±
SEM (n = 3). In B), no statistical difference was observed
across ΔNef infected cells, even at the highest concentration (p
> 0.15). In C), no statistical difference was observed for the
wild-type virus at 3 µM and 6 µM (p >0.345 and >0.325,
respectively) relative to the untreated control. The negative
control compound, TMPyP2, further had no impact on the ΔNef
virus at any concentration tested (p>0.29 at 6 µM). D) TZM-bl
cell viability in the presence of compounds was assessed via
the Cell-Titer Blue assay (Promega). TZM-bl cells were
incubated with the indicated concentrations of compounds for
48 h and cell viability was assessed via the Cell-Titer Blue
assay relative to control cells incubated with carrier solvent.
Assays were done in triplicate.
doi: 10.1371/journal.pone.0073121.g006
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